Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Neurosci Biobehav Rev. 2022 Sep 6;142:104857. doi: 10.1016/j.neubiorev.2022.104857

Fig. 2.

Fig. 2.

Forest plot of interventions with evidence of efficacy in eating disorders.

Results are presented as SMD (ES; CI), ordered by control condition, and by magnitude within the control condition. In forest plot, in black comparisons against Active control, in grey against TAU. Legend: 3WPT, third wave psychotherapies; A, Active control; AC, anticonvulsants; AD, mixed antidepressants; ADU, adults; BEHAV, eating disorder behaviours; BT, behavioural therapy; CBT-ED, cognitive behavioural therapy for eating disorders; CI, confidence interval; EDP, eating disorder psychopathology; ES, effect size; FAM, family therapy; FBT, family-based treatment; g, group therapy; GENSX, general psychiatric symptoms; GLOBAL, response/remission/relapse; HOR, hormones; i, individual therapy; LDX, lisdexamfetamine; MIX, mixed age group; ORL, orlistat; P, placebo; SGAD, second generation antidepressants; SMD, standardized mean difference; SSRI, selective serotonin reuptake inhibitors; T, treatment as usual; TCA, tricyclic antidepressants; TOP, topiramate; WEIGHT/BODY, change in weight or body composition